To review:
The time is taken by enzyme replacement therapy (ERT) to restore the blood adenosine deaminase (ADA) levels and the reason behind the requirement of the weekly injections during the ERT therapy to restore blood ADA and deoxyadenosine level.
Given:
The enzyme replacement therapy was performed in one patient. The dosage of the enzyme, which is measured in milliliter per kilogram (mL/kg), administered to the patient, was increased in the subsequent weeks. In each week plasma, ADA levels were measured in micromole per hour per liter (µmol/h/L), and the data was recorded in the given Table 1 below.
Table 1: The results of enzyme replacement therapy in one patient.
Weeks after initial administration of ADA enzyme | The dosage of enzyme (mL/kg) | Levels of ADA in plasma (µmol/h/L) | Percent of deoxyadenosine with respect to all other adenine |
0 | 0.1 | 0 | 44 |
1 | 0.1 | 2 | 28 |
2 | 0.2 | 3 | 19 |
3 | 0.2 | 7 | 11 |
4 | 0.2 | 8 | 5 |
5 | 0.2 | 5 | 4 |
6 | 0.2 | 4 | 3 |
Introduction:
The ERT can be used to treat the conditions caused by the deficiency of the enzymes. The ADA deficiency is a condition, in which the body is unable to synthesize adenosine deaminase, which causes the accumulation of deoxyadenosine.
This accumulation can be toxic to T-cells, causing their death leading to severe combined immunodeficiency (SCID). The SCID is an inheritable disorder, caused by the mutation in the gene responsible for the coding of ADA protein.
Explanation of Solution
The ERT therapy can help in the restoring the blood ADA level. The patient is given a small quantity of the enzyme (0.1 mL/kg) in the beginning and then the amount is increased to 0.2 mL/Kg. as observed from Table 1, the levels of ADA gets increased in the subsequent weeks. It took around 6 weeks in the patient to restore the normal deoxyadenosine levels, after the administration of the ADA enzyme in the patient.
The weekly injections of ERT are given to the patient, in order to maintain the normal ADA levels in the body. The weekly dose of the enzyme is given to the patients because the patient lacks the gene, which is responsible for the production of ADA.
Thus, it can be concluded that around 6 weeks are required to restore the normal blood ADA levels in the body, which results in the accumulation of less quantity of deoxyadenosine with respect to the other adenine nucleotides. The enzyme injections are given weekly to restore the normal ADA levels in the blood.
Want to see more full solutions like this?
Chapter 41 Solutions
Life: The Science of Biology
- Which patch clamp technique should be used if you want to investigate the effect a compound has presynaptically with varying concentration?arrow_forward Mr. Yeboah, diagnosed with a malignant tumour of the liver had it removed and was given a course of chemotherapy. Initially, tumour marker (AFP) activity activity was 7500KU/L (which is very high) but after treatment, this gradually declined to only 5KU/L. A routine follow up test was perfomedafter 3 months and the results was 15KU/L for AFP. The doctor suspected a relapse of the tumour and so referred Mr. Yeboahto an oncologist at a cancer centre who also did a re-check. AFP was recorded to be 5KU/L. Enquiries revealed that the hospital and the cancer centre use different instruments for the measurement of AFP. Both results are normal even though the values are significantly different because different methods were used.a) How can both labs confirm that the results are not clinically significant? b) How can both labs avoid this happening again?arrow_forwardInsulin Lispro subcutaneously for a patient weight 80 kg for 1 month of treatment. Daily dose of insulin is 1 Unit/kg and 60% in short acting, given 4 times per day; ampoules in form of personal injectors (300 Units/3ml). (I would like to figure out the number of personal injector needed for 1 month.) My answer: Daily dose (DD) for a 80 kg patient = 80 x 1 Unit = 80 U 60% is short acting, so DD = 60% of 80 U = (0.6 × 80) U = 48 U Given 4 times per day, so for a single dose = 48 U/4 = 12 U For 1 month (30 days), 30 x 48U = 1440 U Rp. Insulin lispro in ampoules personal injectors 300 Units/3 ml No. ??? (my teacher write is 10 but I don't understand why) Sig. Inject subcutaneously 12 Unit (0.12 ml) before each meal, 4 times a day for 1 month.arrow_forward
- A patient requires 40 units of NPH insulin and 10 units ofregular insulin daily subcutaneously. What is the correctsequence when mixing insulins?a. Inject air into the regular insulin vial and withdraw 10units; then, using the same syringe, inject air into the NPHvial and withdraw 40 units of NPH insulin.b. Inject air into the NPH insulin vial, being careful not toallow the solution to touch the needle; next, inject air into the regular insulin vial and withdraw 10 units; then, with-draw 40 units of NPH insulin. c. Inject air into the regular insulin vial, being careful not toallow the solution to touch the needle; next, inject air into the NPH insulin vial and withdraw 40 units; then, with-draw 10 units of regular insulin. d. Inject air into the NPH insulin vial and withdraw 40 units;then, using the same syringe, inject air into the regulararrow_forwardA 10-week-old child suffered from a salt-wasting crisis. His adrenal glands were enlarged and other organs were normal size. The child is phenotypically female, karotyping showed that the child is 46XY. The biochemical profile shows as: - sodium of 109 (reference range: 134-147) - potassium of 6.1 (reference range: 3.5-5.0) - pregnenlone of 0.002 (reference range: 0.3-1.5) - renin activity of 38 (reference range: 0.5-3.5) - 17-OH pregnenolone of 0.01 (reference range: 6.8-93.5) - ACTH of 1960 (reference range: 0.5-3.5) The cholesterol esters in the adrenal glands accumulated and the concentration of ∆4-androstenedione was not detectable. Also, the enzymes in the steroid biosynthesis did not have detrimental mutations. The child was given treatment with glucocorticoid and mineralocorticoid. Question: a) Which protein is deficient in this case and explain the rationale.arrow_forwardWhat is the purpose of using the Z-track technique for IM injections.arrow_forward
- The instructions for the azithromycin state to reconstitute the 600 mg vial with 3.6 mL until dissolved, to yield a strength of 150 mg/mL, and then to add it to 270 mL of D5W and administer over at least 60 minutes. At what rate will you set the infusion pump if you choose to administer the medication over 90 minutes? order:arrow_forwardBased on the image below, select the correct statement. Complex II QH₂ Q- 10 2 HO 2 HO Fe-S (2.8 FADH₂ FAD- Succinate Fumarate https://canvas.uts.edu.au/assessment questions/356986/files/1562694/download? 2e verifier-eUTT3hYal2YYTWlywV8TIFA3USmzCsM52jECmvTo O Succinate is reduced to fumarate O Succinate is oxidised to FAD O The Fe-S center shuffles electrons from FAD to ubiquinone (Q) O The Fe-S center shuffles electrons from FADH2 to ubiquinone (Q) The Fe-S center shuffles electrons from FADH2 to ubiquinonol (QH2) W 88 16°Carrow_forwardOf the available types of surgery, why would TURBT be a choice for many patients despite the high risk of relapse post-surgery? Give at least two reasons why patients might select this option.arrow_forward
- The plasma concentration of a drug is 50 mg/L and is decreasing in first-order fashion with a half-life of 12 hours. Approximately how may hours will it take for the blood concentration to fall to a desired range of 10-15 mg/L? (A) 12 (B) 24 (C) 36 (D) 48 (E) 50arrow_forwardKCI for injection contains 40 mEq in 20 mL. An order requires 15 mEq, how many mL are needed?arrow_forwardThe peak plasma concentration achieved after the first IV dose of drug X is 25 mg/L. The drug’s half-life is 3.5 hours, and it is administered every 12 hours. What will be the peak plasma concentration at steady state?arrow_forward
- Essentials of Pharmacology for Health ProfessionsNursingISBN:9781305441620Author:WOODROWPublisher:Cengage